Comparison of Sericins from Different Sources as Natural Therapeutics against Ulcerative Colitis

Sericin has become a promising natural anti-inflammatory protein. However, the biological functions of sericins largely depend on their origins; no study has yet been carried out to comparatively investigate the therapeutic effects of sericins from different sources against inflammatory diseases. Herein, we extracted and purified three kinds of sericins, namely silkworm sericin (SS), tussah sericin (TS), and castor silk sericin (CSS). These sericins showed negligible cytotoxicities against colitis-associated cells (colon epitheliums and activated macrophages). Further investigations displayed that these sericins could remarkably downregulate the secreted amounts of TNF-alpha, promote the recovery of the damaged colonic epithelial barrier, and eliminate endogenous reactive oxygen species in Raw 264.7 macrophages and Caenorhabditis elegans. In vivo experiments demonstrated that chitosan/alginate hydrogel-encapsulating SS could achieve efficient accumulation of SS in the colitis tissues and thereby play a more effective role in relieving ulcerative colitis (UC) than TS and CSS. Our findings collectively demonstrate that SS can be extracted, formulated, and used as a robust therapeutic agent for the oral treatment of UC.

Automated summary

Sericin, extracted from silkworms, tussahs, and castor silk, has shown promising therapeutic effects in treating ulcerative colitis. In vivo experiments demonstrated that chitosan/alginate hydrogel-encapsulating silkworm sericin achieved efficient accumulation in colitis tissues and played a more effective role in relieving UC compared to tussah sericin and castor silk sericin.